Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Delgado

Showing results (51-60 of 1,433) with videos related to

Pageof 144
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2000
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit antigen-induced apoptosis of mature T lymphocytes by inhibiting Fas ligand expressionM Delgado, D Ganea
Annals of the New York Academy of Sciences|February 24, 2001
VIP and PACAP inhibit activation induced apoptosis in T lymphocytesM Delgado, D Ganea
Journal of Neuroimmunology|December 8, 2000
VIP and PACAP inhibit Fas ligand-mediated bystander lysis by CD4(+) T cellsM Delgado, D Ganea
Social Work|April 7, 1998
HIV/AIDS in a Puerto Rican/Dominican community: a collaborative project with a botanical shopM Delgado, J Santiago
Academic Medicine : Journal of the Association of American Medical Colleges|September 11, 2025
Speaking Up for MJanice M Delgado Díaz
Health & Social Work|December 31, 1997
Making the case for culturally appropriate community services: Puerto Rican elders and their caregiversM Delgado, S Tennstedt
Revista Medica De Chile|September 1, 1981
[Poisoning by organo-phosphorate compounds (author's transl)]M Delgado, M Suazo
Journal of Neuroimmunology|October 12, 2000
Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide inhibit the MEKK1/MEK4/JNK signaling pathway in LPS-stimulated macrophagesM Delgado, D Ganea
The Journal of Biological Chemistry|October 13, 2000
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit nuclear factor-kappa B-dependent gene activation at multiple levels in the human monocytic cell line THP-1M Delgado, D Ganea
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2001
Cutting edge: is vasoactive intestinal peptide a type 2 cytokine?M Delgado, D Ganea
Pageof 144

Showing results (51-60 of 1,433) with videos related to

Sort By:
Pageof 144
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2000
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit antigen-induced apoptosis of mature T lymphocytes by inhibiting Fas ligand expressionM Delgado, D Ganea
Annals of the New York Academy of Sciences|February 24, 2001
VIP and PACAP inhibit activation induced apoptosis in T lymphocytesM Delgado, D Ganea
Journal of Neuroimmunology|December 8, 2000
VIP and PACAP inhibit Fas ligand-mediated bystander lysis by CD4(+) T cellsM Delgado, D Ganea
Social Work|April 7, 1998
HIV/AIDS in a Puerto Rican/Dominican community: a collaborative project with a botanical shopM Delgado, J Santiago
Academic Medicine : Journal of the Association of American Medical Colleges|September 11, 2025
Speaking Up for MJanice M Delgado Díaz
Health & Social Work|December 31, 1997
Making the case for culturally appropriate community services: Puerto Rican elders and their caregiversM Delgado, S Tennstedt
Revista Medica De Chile|September 1, 1981
[Poisoning by organo-phosphorate compounds (author's transl)]M Delgado, M Suazo
Journal of Neuroimmunology|October 12, 2000
Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide inhibit the MEKK1/MEK4/JNK signaling pathway in LPS-stimulated macrophagesM Delgado, D Ganea
The Journal of Biological Chemistry|October 13, 2000
Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit nuclear factor-kappa B-dependent gene activation at multiple levels in the human monocytic cell line THP-1M Delgado, D Ganea
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2001
Cutting edge: is vasoactive intestinal peptide a type 2 cytokine?M Delgado, D Ganea
Pageof 144